Press Releases

Date	Title and Summary	Additional Formats
Toggle SummaryJun 15, 2015	Agile Therapeutics to Present at the JMP Securities Life Sciences Conference 2015 Presentation Scheduled on Tuesday, June 23th, 2015 at 9:00 AM ET...	Agile Therapeutics to Present at the JMP Securities Life Sciences Conference 2015 15.2 KB
Toggle SummaryJun 12, 2015	Agile Therapeutics Announces Issuance of Patent for Twirla(R) Patch Design Intellectual Property Portfolio Broadened for Its Proprietary Transdermal Delivery System...	Agile Therapeutics Announces Issuance of Patent for Twirla(R) Patch Design 16.3 KB
Toggle SummaryMay 28, 2015	Agile Therapeutics to Present at the William Blair 35th Annual Growth Stock Conference Presentation Scheduled on Tuesday, June 9, 2015 at 2:10 PM Central Time...	Agile Therapeutics to Present at the William Blair 35th Annual Growth Stock Conference 15.1 KB
Toggle SummaryMay 12, 2015	Agile Therapeutics Reports First Quarter Financial Results SECURE Trial Continues to Progress...	Agile Therapeutics Reports First Quarter Financial Results 25.3 KB
Toggle SummaryApr 7, 2015	Agile Therapeutics to Present at the 14th Annual Needham Healthcare Conference Presentation Scheduled on Wednesday, April 15, 2015 at 4:20 PM Eastern Time...	Agile Therapeutics to Present at the 14th Annual Needham Healthcare Conference 14.8 KB
Toggle SummaryMar 26, 2015	Agile Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results Begins 2015 in a Stronger Financial Position...	Agile Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results 26.8 KB
Toggle SummaryMar 2, 2015	Agile Therapeutics to Present at the 27th Annual ROTH Conference Presentation Scheduled on Monday, March 9th, 2015 at 4:30 PM Pacific Time...	Agile Therapeutics to Present at the 27th Annual ROTH Conference 14.7 KB
Toggle SummaryFeb 24, 2015	Agile Therapeutics Secures Debt Facility From Hercules Technology Growth Capital of Up to $25.0 Million and Provides Update on Status of Clinical Trial PRINCETON, N.J. , Feb. 24, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has entered into a loan and security...	Agile Therapeutics Secures Debt Facility From Hercules Technology Growth Capital of Up to $25.0 Million and Provides Update on Status of Clinical Trial 21.1 KB
Toggle SummaryFeb 12, 2015	Agile Therapeutics to Present at the 2015 RBC Capital Markets' Global Healthcare Conference Presentation Scheduled on Wednesday, February 25th, 2015 at 11:00 AM ET...	Agile Therapeutics to Present at the 2015 RBC Capital Markets' Global Healthcare Conference 15.3 KB
Toggle SummaryJan 20, 2015	Agile Therapeutics Announces $20 Million Private Placement and Provides Clinical Trial Update PRINCETON, New Jersey , Jan. 20, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has entered into a definitive...	Agile Therapeutics Announces $20 Million Private Placement and Provides Clinical Trial Update 19.4 KB